Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Primary objective of the study is to investigate the efficacy of vorinostat in patients
suffering from selected histological types of soft tissue sarcoma. Further evaluations relate
to the safety and tolerability of vorinostat, its pharmacokinetics (course of plasma
concentration over time) and pharmacodynamics (mode of action). Only subjects with advanced,
metastatic disease will be included in this trail.